Related Experiment Video
Updated: Aug 6, 2026
Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Weakened macrophage antibacterial capacity in myelodysplastic syndrome
Johnathon B Schafer1,2,3, Kenneth C Malcolm4,5, Jessica Dell-Martin6
1Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, United States.
Abstract:
Patients with myelodysplastic syndrome (MDS) are immunocompromised and are therefore susceptible to fatal infection. While neutropenia and neutrophil dysfunction account for much of this immunodeficiency, other immune cells likely also contribute. In contrast to the extensive study of neutrophils in MDS, there has been very little investigation of macrophage host defense function in MDS. In the current study, we find that macrophage differentiation and macrophage phagocytosis of bacteria are greatly weakened in patients with MDS, regardless of patient genotype. Moreover, we find that killing of those bacteria that are ingested is diminished in MDS patients with high-risk disease. Using a mouse model that expresses the MDS-associated U2AF1-S34F mutation, we find that this mutation is sufficient to induce macrophage functional defects. We conclude that macrophage host defense defects likely contribute to the immunodeficiency present in MDS.
Insights
Patients with myelodysplastic syndromes (MDS) have weakened macrophage immune cell function, impairing their ability to fight bacterial infections. This defect, seen across MDS subtypes, contributes to increased infection susceptibility in these patients.
Area of Science:
- Immunology
- Hematology
- Infectious Disease
Background:
- Patients with myelodysplastic syndromes (MDS) exhibit increased susceptibility to infections due to compromised immunity.
- While neutrophil defects are well-documented in MDS, the role of other immune cells, like macrophages, remains understudied.
- Understanding macrophage function is crucial for a comprehensive view of immune dysfunction in MDS.
Purpose of the Study:
- To investigate the host defense function of macrophages in patients with myelodysplastic syndromes (MDS).
- To determine if macrophage differentiation, phagocytosis, and bacterial killing are impaired in MDS.
- To explore the impact of MDS-associated mutations on macrophage function using a mouse model.
Main Methods:
- Assessed macrophage differentiation and phagocytic capacity in MDS patients.
- Quantified bacterial killing by macrophages from MDS patients.
- Utilized a mouse model expressing the U2AF1-S34F mutation, common in MDS, to study macrophage defects.
Main Results:
- Macrophage differentiation and phagocytosis of bacteria were significantly reduced in MDS patients, irrespective of genotype.
- Impaired bacterial killing was observed in macrophages from high-risk MDS patients.
- The MDS-associated U2AF1-S34F mutation was sufficient to induce macrophage functional deficits in a mouse model.
Conclusions:
- Macrophage dysfunction, including impaired differentiation, phagocytosis, and bacterial killing, is a significant feature of myelodysplastic syndromes.
- These macrophage defects likely contribute to the increased risk of fatal infections in MDS patients.
- Targeting macrophage function may offer novel therapeutic strategies for improving host defense in MDS.
